View Older Stories View More Recent Stories
-
CVS Health (CVS) PT Lowered to $99 at Piper Sandler
-
HHS and CMS Announce New Members of New Federal Advisory Board
-
UBS Reiterates Buy Rating on CVS Health (CVS)
-
Leerink Partners on CVS Health (CVS): potential settlement removes uncertainty clouding PBM biz
-
CVS Health appoints former Elevance Health CFO to board
-
Street Calls of the Week
-
TD Cowen Reiterates Buy Rating on CVS Health (CVS)
-
CVS Health Deepens Commitment to Nashville With $120,000 Investment in Cul2vate's "Roots and Roofs" Initiative
-
Bernstein SocGen Group Upgrades CVS Health (CVS) to Outperform
-
CVS Health Boosts CVS Pharmacy Customer Generosity To Address Food Insecurity
-
Leerink Partners Reiterates Outperform Rating on CVS Health (CVS), partnership with Google Cloud "positive AI development"
-
Truist on CVS Health (CVS): 'We Remain Bullish On The Heels Of Upbeat Management Meetings'
-
CVS Health 2025 Rx Report Highlights Transformation of Community Pharmacy To Meet Patient Needs
-
CVS Pharmacy Partners with U.S. Soccer Federation and National Women's Soccer League to Promote Community Health and Wellness
-
CVS Health Announces $5 Million Scholarship Program To Support Future Pharmacists in Louisiana
-
CVS Health (CVS) Tops Q4 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
-
CVS Health preview - Medicare headwinds against retail, PBM growth
-
CVS Health (CVS) call put ratio 1 call to 1 put into quarter results
-
CVS Health pharmacies now accept TrumpRx discount cards
-
CVS Health adds biosimilar osteoporosis drugs to formulary
-
Aetna launches digital benefits onboarding for four million members
-
CVS Caremark is negotiating potential settlement of U.S. FTC's insulin pricing claims - Reuters
-
Health insurers slide after 2027 Medicare Advantage payments proposal underwhelms
-
Piper Sandler: 'We Would Be Buyers of ALHC, CVS on Selloff, UNH Post-EPS'
-
CVS Health (CVS) call put ratio 1.7 calls to 1 put
-
CVS Health (CVS) PT Lowered to $95 at BofA Securities
-
After-hours movers: Humana, UnitedHealth, CVS Health, Sanmina and more
-
Trump Administration Proposes Flat Rates for Medicare Advantage, CMS and White House Say -- WSJ
-
House Judiciary GOP accuses CVS Health of stifling competition
-
CVS Health (CVS) call put ratio 1 call to 1 put as share price up 1%
-
Cantor: 'Our preference to play MA in '26 is CVS & UNH'
-
CVS Health (CVS) call put ratio 1 call to 1.2 puts
-
Hunterbrook Research accuses Big Three health insurers of using shell companies
-
CVS Health (CVS) Declares $0.665 Quarterly Dividend; 3.3% Yield
-
Morgan Stanley asks: Is UNH "the CVS of 2026"?
-
BofA Comments on GLP-1s and Potential Pressure Ahead
-
CVS Health (CVS) PT Raised to $87 at Bernstein SocGen Group
-
CVS Health (CVS) PT Raised to $101 at Piper Sandler as 'CY25 Execution Builds Trust'
-
CVS Health (CVS) Still Steady Operator With Strong Management - Cantor Fitzgerald
-
CVS Health (CVS) PT Raised to $93 at Morgan Stanley
-
CVS Health (CVS) PT Raised to $98 at Truist Securities
-
RBC Capital Reiterates Outperform Rating on CVS Health (CVS)
-
CVS Health (CVS) PT Raised to $97 at UBS
-
BofA Securities Reiterates Buy Rating on CVS Health (CVS)
-
CVS Health (CVS) PT Raised to $95 at Mizuho
-
CVS Health (CVS) PT Raised to $105 at TD Cowen
-
CVS Health raises 2025 financial guidance, targets mid-teens EPS growth
-
CVS Health investor day: analysts eye turnaround momentum
-
CVS Health (CVS) PT Raised to $86 at Bernstein
-
RBC Capital Reiterates Outperform Rating on CVS Health (CVS)
